Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

NCT00379977 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus
Haemophilus Influenzae Type b
Acellular Pertussis
Diphtheria

Interventions

BIOLOGICAL: diphtheria, tetanus, pertussis & Hib vaccine

Sponsor

GlaxoSmithKline